Athenahealth
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Athenahealth's revenues will increase 25.4% and EPS will grow 64.3%.
The average estimate for revenue is $121.1 million. On the bottom line, the average EPS estimate is $0.23.
Revenue details
Last quarter, Athenahealth reported revenue of $116.3 million. GAAP reported sales were 26% higher than the prior-year quarter's $92.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $0.29. GAAP EPS of $0.15 were the same as the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 61.1%, 130 basis points worse than the prior-year quarter. Operating margin was 10.9%, 10 basis points worse than the prior-year quarter. Net margin was 5.1%, 70 basis points worse than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $542.0 million. The average EPS estimate is $1.22.
Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 191 members out of 249 rating the stock outperform, and 58 members rating it underperform. Among 68 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 55 give Athenahealth a green thumbs-up, and 13 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Athenahealth is hold, with an average price target of $79.18.
Is Athenahealth the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Athenahealth to My Watchlist.
